Physician profile
Roxana Rodriguez
NPI 1053994616
$3,065.90
in general payments reported to CMS, 2019-2025
24 companies · $821 in 2025
The $821 reported for 2025 was more than what 82% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.38 · 2022: $212 · 2023: $900 · 2024: $1,092 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,539 · Education: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,538.68 |
| Education | $274.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $699.30 | 2023-2025 | |
| Janssen Biotech, INC. | $526.95 | 2021-2024 | Erleada, Imbruvica, Darzalex |
| Merck Sharp & Dohme LLC | $322.37 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Takeda Pharmaceuticals U.S.A., INC. | $228.58 | 2023-2025 | Vpriv, Fruzaqla, Ninlaro |
| Bayer Healthcare Pharmaceuticals INC. | $161.99 | 2023-2025 | |
| Lilly USA, LLC | $129.06 | 2023-2025 | Verzenio, Jaypirca |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 2024 | |
| Novartis Pharmaceuticals Corporation | $110.72 | 2021-2025 | |
| Adaptive Biotechnologies Corporation | $107.06 | 2023-2025 | Clonoseq |
| Gilead Sciences, INC. | $106.04 | 2022 | |
| Seagen INC. | $92.99 | 2025 | |
| Sobi, INC | $88.54 | 2023 | |
| Daiichi Sankyo INC. | $86.58 | 2023-2024 | Enhertu |
| Genzyme Corporation | $52.19 | 2023 | |
| Tolmar, INC. | $29.56 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $25.16 | 2024 | |
| Array Biopharma INC | $24.08 | 2024 | Tukysa, Braftovi, Mektovi |
| Foundation Medicine, INC. | $23.11 | 2023 | |
| Biogen, INC. | $22.52 | 2022 | |
| Agios Pharmaceuticals, INC. | $22.47 | 2024 | Pyrukynd |
| Tersera Therapeutics LLC | $21.78 | 2025 | Zoladex |
| Astellas Pharma US INC | $20.67 | 2024 | Vyloy |
| Hologic Sales and Service, LLC | $19.63 | 2023 | Thinprep 2000 Processor, Aptima |
| Immunogen, INC. | $19.56 | 2023 | Elahere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roxana Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.